Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale The "fear-potentiated startle" paradigm has been extensively used in animal studies, and more recently in human experimental psychopharmacology to evaluate the effects of anxiogenic and anxiety-relieving drugs. Previous human studies have shown that both the baseline and the fear-potentiated responses can be inhibited by anxiety-relieving drugs, suggesting drug activity on two different emotional states, the former reflecting a resting condition and the latter more akin to pathological anxiety.Objectives To examine to which extent the reductions induced by a benzodiazepine on the basic and the fear-potentiated startle responses are of equal intensity, and whether or not the drug shows a predominant, i.e., selective, effect on either.Methods The effects of three increasing doses of the benzodiazepine alprazolam (0.25, 0.5, and 1.0 mg) were assessed on the human baseline and fear-potentiated startle responses. Twelve healthy volunteers attended the laboratory on four experimental days and received either alprazolam or placebo according to a double-blind crossover balanced design. Startle recordings were undertaken 2 h after drug intake. Fear potentiation was implemented by means of an electric-shock-anticipation experimental procedure. Additionally, subjective self-reports of sedation and anxiety and psychomotor performance were obtained at 2 and 3 h, respectively, after drug administration.Results Alprazolam dose-dependently impaired psychomotor performance and produced increases in subjective anxiolytic activity and sedation, although the latter did not reach statistical significance. Additionally, the drug reduced the magnitude of the startle response both in the absence and in the presence of a threat-related cue, although a differentially greater inhibitory effect was seen on the fear-potentiated response as the dose increased.Conclusions Alprazolam showed a greater inhibitory effect on the fear-potentiated startle than on the baseline reflex, suggesting a more selective action of the drug on those structures mediating potentiation of the behavioral response by anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initial studies found that diazepam (Bitsios et al, 1999) and alprazolam (Riba et al, 2001) decreased fear-potentiated startle during a verbal threat procedure in which short-duration threat cues predicted a shock, but these findings were not confirmed in several studies using various benzodiazepines (Baas et al, 2002; Grillon et al, 2006b; Riba et al, 1999; Scaife et al, 2005).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Riba et al, 2001
Citations
Cites
(1970) · Cited by 24,983
Guidelines for Human Electromyographic Research
Fridlund, A. J., & Cacioppo, J. T. (1986) · Psychophysiology · doi:10.1111/j.1469-8986.1986.tb00676.x · Cited by 1,737
The Mammalian Startle Response
Davis, M. (1984) · Neural Mechanisms of Startle Behavior · doi:10.1007/978-1-4899-2286-1_10 · Cited by 567
Fear‐Potentiated Startle in Humans: Effects of Anticipatory Anxiety on the Acoustic Blink Reflex
Grillon, C., AMELI, R., Woods, S. W., Merikangas, K., & Davis, M. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb01999.x · Cited by 462 · cited 2×
“This effect of the threat-of-shock on onset latency also replicates the results obtained by other research groups (Grillon et al. 1991, 1993; Curtin et al. 1998; Grillon and Ameli 1998; Bitsios et al. 1999).”
ResultHitchcock, J. M., & Davis, M. (1991) · Behavioral Neuroscience · doi:10.1037/0735-7044.105.6.826 · Cited by 345 · cited 1×
“Conversely, lesions selectively affecting the pathway connecting the central nucleus of the amygdala with the nucleus reticularis pontis caudalis have been shown to block fear-potentiated startle (Hitchcock and Davis 1991).”
BackgroundDavis, M. (1986) · Behavioral Neuroscience · doi:10.1037//0735-7044.100.6.814 · Cited by 343
Use of benzodiazepines in anxiety disorders
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281907 · Cited by 341
Davis, M. (1979) · Psychopharmacology · doi:10.1007/bf00426027 · Cited by 263
Davis, M., Redmond, D. E., & Baraban, J. M. (1979) · Psychopharmacology · doi:10.1007/bf00433036 · Cited by 259
Rosen, J. B., Hitchcock, J. M., Sananes, C. B., & Miserendino, M. J. (1991) · Behavioral Neuroscience · doi:10.1037//0735-7044.105.6.817 · Cited by 255
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Clinical biomarkers in drug discovery and development
Frank, R., & Hargreaves, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1130 · Cited by 794
Grillon, C., & Baas, J. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00202-5 · Cited by 563
Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology
Grillon, C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01665-7 · Cited by 494
Models and mechanisms of anxiety: evidence from startle studies
Grillon, C. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1019-1 · Cited by 456
“These results have been confirmed by some (Riba et al. 1999; Scaife et al. 2005), but not others (Bitsios et al. 1999; Riba et al. 2001; see Grillon and Baas 2002; Walker and Davis 2002b for a discussion of issues related to the effect of benzodiazepines on fear-potentiated startle).”
BackgroundResultPavlovian Conditioning: A Functional Perspective
Domjan, M. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141409 · Cited by 360
Anxious Responses to Predictable and Unpredictable Aversive Events.
Grillon, C., Baas, J. P., Lissek, S., Smith, K., & Milstein, J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.5.916 · Cited by 349
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
Whiting, P. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02703-x · Cited by 326
Avital, A., & Richter-Levin, G. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004808 · Cited by 219
Kaviani, H., Gray, J. A., Checkley, S. A., Raven, P. W., Wilson, G. D., & Kumari, V. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.04.007 · Cited by 190
Grillon, C., Cordova, J., Levine, L. R., & Morgan, III (2003) · Psychopharmacology · doi:10.1007/s00213-003-1444-8 · Cited by 185
Grillon, C., Baas, J. M. P., Pine, D. S., Lissek, S., Lawley, M., Ellis, V., & Levine, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.027 · Cited by 157
Verster, J. C., & Volkerts, E. R. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00003.x · Cited by 150
The acute effects of L‐theanine in comparison with alprazolam on anticipatory anxiety in humans
Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., Phan, K. L., & Nathan, P. J. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.611 · Cited by 139
“, 2003a, 2003b), and psychological (experimental) methods such as extemporaneous public speaking, aversive conditioning, fear-potentiated startle response, Stroop colour word task performance and anticipation of electric shock (Baas et al., 2002; Chua et al., 1999; Graeff, 2002, 2003; Grillon and Ameli, 2001; Grillon…”
BackgroundInfluentialWalker, D., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1213-0 · Cited by 122
Benzodiazepines have no effect on fear-potentiated startle in humans
Baas, J., Grillon, C., Böcker, K., Brack, A., Morgan, C., Kenemans, L., & Verbaten, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1011-8 · Cited by 116
Perkins, A. M., Ettinger, U., Weaver, K., Schmechtig, A., Schrantee, A., Morrison, P. D., Sapara, A. O., Kumari, V., Williams, S., & Corr, P. J. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.20 · Cited by 89
Pharmacology of human experimental anxiety
Graeff, F. G., Parente, A., Del-Ben, C. M., & Guimarães, F. S. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000400003 · Cited by 70
“- Riba et al. ( 54 ) Ethanol Drink 0 Curtin et al. (55)”
Juvenile stress-induced alteration of maturation of the GABAA receptor α subunit in the rat
Jacobson-Pick, S., Elkobi, A., Vander, S., Rosenblum, K., & Richter-Levin, G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008559 · Cited by 68
A neurophysiological study of the detrimental effects of alprazolam on human action monitoring
Riba, J., Rodríguez‐Fornells, A., Münte, T. F., & Barbanoj, M. J. (2005) · Cognitive Brain Research · doi:10.1016/j.cogbrainres.2005.08.009 · Cited by 72
Self-citationEmotion regulation and potentiated startle across affective picture and threat-of-shock paradigms
Lissek, S. M., Orme, K., McDowell, D., Johnson, L. L., Luckenbaugh, D. A., Baas, J. M. P., Cornwell, B. R., & Grillon, C. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.07.002 · Cited by 59
Phasic and Sustained Fear are Pharmacologically Dissociable in Rats
Miles, L., Davis, M., & Walker, D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.29 · Cited by 47
Lorazepam dose-dependently decreases risk-taking related activation in limbic areas
Arce, E., Miller, D. A., Feinstein, J. S., Stein, M. B., & Paulus, M. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0519-8 · Cited by 46
Nordquist, R. E., Steckler, T., Wettstein, J. G., Mackie, C. E., & Spooren, W. P. J. M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1096-9 · Cited by 40
An updated overview of animal models in neuropsychiatry
Razafsha, M., Behforuzi, H., Harati, H., Wafai, R. A., Khaku, A. S., Mondello, S., Gold, M. S., & Kobeissy, F. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.045 · Cited by 44
Darbra, S., & Pallarés, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.020 · Cited by 40
Effects of lorazepam on fear-potentiated startle responses in man
Graham, S. J., Scaife, J. C., Langley, R. W., Bradshaw, C. M., Szabadi, E., Xi, L., Crumley, T., Calder, N., Gottesdiener, K., & Wagner, J. A. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051528 · Cited by 34
Kask, K., Bäckström, T. C., Lundgren, P., & Poromaa, I. S. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.02.014 · Cited by 31
No effect of sex and estrous cycle on the fear potentiated startle response in rats
Zhao, Y., Bijlsma, E. Y., Verdouw, M. P., & Groenink, L. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.022 · Cited by 31
C., G., & J., B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1164-5 · Cited by 27
“Benzodiazepines have been shown to reduce fear-potentiated startle in some studies (Bitsios et al. 1999; Riba et al. 2001), but not in others (Riba et al.”
ResultMethod development studies for repeatedly measuring anxiolytic drug effects in healthy humans
Klumpers, F., van Gerven, J., Prinssen, E., Niklson Roche, I., Roesch, F., Riedel, W., Kenemans, J., & Baas, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109103115 · Cited by 27
Startle potentiation in rapidly alternating conditions of high and low predictability of threat
Mol, N., Baas, J. M. P., Grillon, C., der Linden, L. V. O.-V., & Kenemans, J. L. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.05.005 · Cited by 28
Effects of anxiolytic treatment on potentiated startle during aversive image anticipation
Acheson, D. T., Stein, M. B., Paulus, M. P., Ravindran, L. N., Simmons, A. N., Lohr, J. B., & Risbrough, V. B. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2243 · Cited by 23
Baas, J. M. P., Mol, N., Kenemans, J. L., Prinssen, E. P. M., Niklson, I. A., Xia-Chen, C., Broeyer, F. J. F., & van Gerven, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1516-5 · Cited by 23
Behavioral Correlates of Anxiety
Risbrough, V. B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_11 · Cited by 25
Heldt, S. A., Davis, M., Ratti, E., Corsi, M., Trist, D. G., & Ressler, K. J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832ec594 · Cited by 23
Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice
Smith, K. S., Meloni, E. G., Myers, K. M., Van’t Veer, A., Carlezon, W. A., & Rudolph, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2026-1 · Cited by 19
Effects of Additional Oxazepam in Long-Term Users of Oxazepam
Oude Voshaar, R. C., Verkes, R.-J., van Luijtelaar, G. L. J. M., Edelbroek, P. M., & Zitman, F. G. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150219.59056.d0 · Cited by 19
Behavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving Impairments
Stone, B. T., Correa, K. A., Brown, T. L., Spurgin, A. L., Stikic, M., Johnson, R. R., & Berka, C. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01799 · Cited by 23
Recurrence of major depressive disorder is predicted by inhibited startle magnitude while recovered
O’Brien-Simpson, L., Parsia, P. D., Simmons, J. G., & Allen, N. B. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.022 · Cited by 19
Characterization of the cerebral activity by time–frequency representation of evoked EEG potentials
Claria, F., Vallverdú, M., Riba, J., Romero, S., Barbanoj, M. J., & Caminal, P. (2011) · Physiological Measurement · doi:10.1088/0967-3334/32/8/021 · Cited by 19
Self-citationGroenink, L., Verdouw, P. M., Zhao, Y., ter Heegde, F., Wever, K. E., & Bijlsma, E. Y. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06307-1 · Cited by 13
Zahova, S. K., Humby, T., Davies, J. R., Morgan, J., & Isles, A. R. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01561-x · Cited by 14
Tracking explicit and implicit long-lasting traces of fearful memories in humans
Packard, P. A., Rodríguez‐Fornells, A., Stein, L. M., Nicolás, B., & Fuentemilla, L. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.09.004 · Cited by 13
Self-citationModelling Anxiety in Humans for Drug Development
Siepmann, M., & Joraschky, P. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077114 · Cited by 8
Tiermodelle für Angst und Angststörungen
Pawlak, C. R., & Weyers, P. (2006) · Psychologische Rundschau · doi:10.1026/0033-3042.57.3.139 · Cited by 6
Fullana, M. A., Caseras, X., Riba, J., Barbanoj, M. J., & Torrúbia, R. (2005) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.07.008 · Cited by 6
Self-citationPraveen, M., & Paramanik, V. (2024) · Brazilian Journal of Science · doi:10.14295/bjs.v4i1.681 · Cited by 2
Fear Not: Neurobiological Mechanisms of Fear and Anxiety
Klumpers, F. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
An Unusual, Paradoxical Arousal with Alprazolam in a Dependant User
Roy, P., & Kar, S. K. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.2.229 · Cited by 1
Brunner, L.-M., Maurer, F., Weber, K., Weigl, J., Milenkovic, V. M., Rupprecht, R., Nothdurfter, C., & Mühlberger, A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06111-x · Cited by 2
Shin, A., Jang, B., Cho, S., Kim, Y. S., Park, M. S., Park, K.-I., Kim, Y. W., & Kim, C. O. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-024-00427-9 · Cited by 1
Zahova, S. K., Humby, T., Davies, J. R., Morgan, J., & Isles, A. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.26.428232 · Cited by 1
Finn, J. L., & Nybell, L. M. (2001) · Cited by 1
Kask, K. (2008) · Uppsala University Publications (Uppsala University)
Predator cognition and the evolution of deimatic displays
Holmes, G. G. (2019)
Bahr, L. (2020) · University of Regensburg Publication Server (University of Regensburg) · Cited by 1
(2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.358
Docking, ADME toxicity analysis of Alprazolam derivatives as potent anxiolytic drugPreprint
Praveen, M., & Paramanik, V. (2022) · Research Square · doi:10.21203/rs.3.rs-2114568/v1
On the anxiogenic influence of serotonin
Näslund, J. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metadata
- Authors
- Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., & Barbanoj, M.
- Affiliations
- Hospital de Sant Pau (ES)
- Venue
- Psychopharmacology
- Published
- 2001-10-01
- Volume
- 157
- Issue
- 4
- Pages
- 358-367
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2062985347
- Cited by
- 60
- References
- 34
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- alprazolam, benzodiazepines, fear-potentiated startle, startle response, anxiety, dose-response relationship, sedation, psychomotor performance, anxiolytic effects, drug selectivity
- MeSH terms
- Acoustic Stimulation, Adult, Alprazolam, Blinking, Dose-Response Relationship, Drug, Double-Blind Method, Fear, Female, Humans, Male, Psychomotor Performance, Reaction Time, Reflex, Startle, Anti-Anxiety Agents, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.